Cargando…

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change

BACKGROUND: The recent reports on the decreasing susceptibility of Plasmodium falciparum to artemisinin derivatives along the Thailand and Myanmar border are worrying. Indeed it may spread to India and then Africa, repeating the same pattern observed for chloroquine resistance. Therefore, it is esse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tinto, Halidou, Bonkian, Léa N, Nana, Louis A, Yerbanga, Isidore, Lingani, Moussa, Kazienga, Adama, Valéa, Innocent, Sorgho, Hermann, Kpoda, Hervé, Guiguemdé, Tinga Robert, Ouédraogo, Jean Bosco, Mens, Petronella F, Schallig, Henk, D’Alessandro, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049403/ https://www.ncbi.nlm.nih.gov/pubmed/24885950 http://dx.doi.org/10.1186/1475-2875-13-207

Ejemplares similares

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2015)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2020)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
por: Valea, Innocent, et al.
Publicado: (2012)

Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans
por: Sondo, Paul, et al.
Publicado: (2019)

Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2018)

Pathogens associated with acute diarrhea, and comorbidity with malaria among children under five years old in rural Burkina Faso
por: Lompo, Palpouguini, et al.
Publicado: (2021)

Traitement préventif intermittent à la sulfadoxine – pyriméthamine du paludisme chez les femmes enceintes: efficacité et observance dans deux hôpitaux urbains du Burkina Faso
por: Bamba, Sanata, et al.
Publicado: (2013)

Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2021)

Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine
por: Tahita, Marc C., et al.
Publicado: (2015)

Polymorphisme de Plasmodium falciparum et mutations des gènes de résistance Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2021)

Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2022)

Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020)

Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
por: Natama, Hamatandi Magloire, et al.
Publicado: (2021)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2023)

Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis
por: Lingani, Moussa, et al.
Publicado: (2021)

Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique
por: Tinto, Halidou, et al.
Publicado: (2015)

Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
por: Noori, Navideh, et al.
Publicado: (2021)

In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice
por: Bonkian, Léa Nadège, et al.
Publicado: (2018)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2020)

Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2021)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
por: Lingani, Moussa, et al.
Publicado: (2023)

Low birth weight and its associated risk factors in a rural health district of Burkina Faso: a cross sectional study
por: Lingani, Moussa, et al.
Publicado: (2022)

Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes
por: Valea, Innocent, et al.
Publicado: (2010)

Age-modified factors associated with placental malaria in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2022)

Epidemiological and clinical aspects of urogenital schistosomiasis in women, in Burkina Faso, West Africa
por: Zida, Adama, et al.
Publicado: (2016)

Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso
por: Brabin, Bernard, et al.
Publicado: (2019)

Socioeconomic and environmental factors associated with malaria hotspots in the Nanoro demographic surveillance area, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Household costs associated with seeking malaria treatment during pregnancy: evidence from Burkina Faso and The Gambia
por: Duval, Laetitia, et al.
Publicado: (2022)

Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_040q39o1f4au9sfjrgfps4s0a7